Table 3.
Drug Class and Corresponding Adverse Drug Events in the ICU-RC.a
| Drug Class Involved in ADE Experienced (n = 10) |
n = 56 | ADE Experienced |
|---|---|---|
| β-Blockers | 1 (2%) | Fatigue |
| Insulin | 1 (2%) | Hypoglycemia |
| Leukotriene receptor antagonists | 1 (2%) | Hallucinations |
| Opiates | 1 (2%) | Constipation |
| Sedatives | 1 (2%) | Oversedation |
| Antibiotics | 2 (4%) | Emesis, nausea |
| Steroids | 3 (5%) | Insomnia, peripheral edema, thrush |
|
| ||
| Drug Class Involved in ADE Prevention Measures Initiated (n = 21) | ADE Preventive Measures Initiated Against | |
|
| ||
| Analgesics (nonopiates) | 1 (2%) | Overdose |
| Antiplatelet | 1 (2%) | Thrombosis |
| Bronchodilators | 1 (2%) | Overdose |
| Decongestants | 1 (2%) | Overdose |
| Oral diabetes medications | 1 (2%) | Hypoglycemia |
| Sedatives | 2 (4%) | Dizziness (n = 1), oversedation (n = 1) |
| Antibiotics | 3 (5%) | Nausea (n = 2), photosensitivity (n = 1) |
| Proton pump inhibitors | 3 (5%) | Osteoporosis |
| Opiates | 4 (8%) | Constipation (n = 3), overdose (n = 1) |
| Steroids | 4 (8%) | Thrush |
Abbreviations: ADE, adverse drug event; ICU-RC, intensive care unit recovery center
a
Data presented as n (%).